The majority of ABOi patients showed an uncomplicated clinical course and graft survival censored for death at 1 year, 3 years, and 5 years was 96%, 90%, and 90% compared to, respectively, 98%, 96%, and 96% in the ABOc group (Figure 1).
In accordance with a number of other studies [8-11], the graft survival of ABOi kidney transplants was not significantly different from matched ABOc kidney transplants.
Abbreviations ABOi: ABO blood group incompatible ABOc: ABO blood group compatible PRA: Panel reactive antibodies AMR: Antibody-mediated rejection.
(1998), in a 10-year review of 50 ABOI transplants with A2 donors at their center from 1986 to 1996, found that results were equivalent to ABOC transplants.
The results in many studies have been comparable to ABOC transplant, but not in others.